Identification, assessment and management of “endocrine disruptors” in wildlife in the EU substance legislation—Discussion paper from the German Federal Environment Agency (UBA).

Highlights: [•] Consistency in the identification, assessment and management of ED substances is needed. [•] Scientifically robust weight-of-evidence approaches for regulatory decision making are needed. [•] More debates on socioeconomic benefits in the context of decision making are needed. [ABSTRACT FROM AUTHOR]